Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study
Author(s):
Dougados, M.; Heijde, D. van der; Chen, Y.C.; Greenwald, M.; Drescher, E.; Liu, J.J.; Beattie, S.; Witt, S.; Torre, I. de la; Gaich, C.; Rooney, T.; Schlichting, D.; Bono, S. de; Emery, P.
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-01-31
Language
English
Is part of
Annals of the Rheumatic Diseases (2017), Vol. 76, no. 1, p. 88-95
